New Delhi: The dose of booster is not the current central theme in scientific and public health discussions, health officials say it underlines that the full vaccination of two doses remains a top priority.
Responding to the query in the ICMR study that shows anti-body decreased in about four months, Director of the Board of Indian (ICMR) Director General Dr.
Balram Bhargava said measuring the level of antibodies was not the only size that could have other individual immunity such as cellular immunity, antibody immunity, mucous immunity And this survives.
“Important understanding is the full vaccination of both doses is very important and there should be no damage in that matter,” he said.
So far, 62% of the total population of adults above 18 have received at least one dose of covid vaccine, while 20% have obtained both doses, the government said.
In September so far, daily vaccination reached an average of 74.4 lakh doses, up from 59.19 lakh in August.
Some states and UTS such as Lakshadweep, Chandigarh, Goa and Himachal Pradesh have reached 100% coverage of the first dose in their adult population.
Sikkim has given the first dose of up to 99% of adults.
Other countries and UTS such as Andaman & Nicobar, Dadar & Nagar Haveli, Ladakh, Uttarakhand and important Kerala have experienced a high number of cases, also have more than 85% coverage of the first dose in 18 populations.
The government aims to achieve more than 80% coverage for the first dose in the adult population in the final October and covers the majority of these segments with both doses by the end of this year.
ICMR: does not focus on booster at this time
